Sumitomo Pharma Co., Ltd.
4506.T · JPX
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Market Cap | ¥289,624 | ¥161,301 | ¥321,807 | ¥479,930 |
| - Cash | ¥23,116 | ¥29,047 | ¥143,478 | ¥202,984 |
| + Debt | ¥305,422 | ¥418,884 | ¥346,372 | ¥284,544 |
| Enterprise Value | ¥571,930 | ¥551,138 | ¥524,701 | ¥561,490 |
| Revenue | ¥398,832 | ¥314,558 | ¥555,544 | ¥560,035 |
| % Growth | 26.8% | -43.4% | -0.8% | – |
| Gross Profit | ¥245,395 | ¥187,981 | ¥376,625 | ¥402,908 |
| % Margin | 61.5% | 59.8% | 67.8% | 71.9% |
| EBITDA | ¥56,673 | -¥281,072 | -¥3,498 | ¥124,359 |
| % Margin | 14.2% | -89.4% | -0.6% | 22.2% |
| Net Income | ¥23,634 | -¥314,969 | -¥74,512 | ¥56,413 |
| % Margin | 5.9% | -100.1% | -13.4% | 10.1% |
| EPS Diluted | 59.49 | -792.79 | -187.55 | 141.99 |
| % Growth | 107.5% | -322.7% | -232.1% | – |
| Operating Cash Flow | ¥16,500 | -¥241,893 | ¥11,937 | ¥31,239 |
| Capital Expenditures | -¥13,030 | -¥15,730 | -¥12,742 | -¥13,494 |
| Free Cash Flow | ¥3,470 | -¥257,623 | -¥805 | ¥17,745 |